Evidence map›Paper›PMID 33431042›Full record

ArticleJournal of cheminformatics2020

Evaluation of deep and shallow learning methods in chemogenomics for the prediction of drugs specificity.

Benoit Playe, Veronique Stoven

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Transfer learning for drug-target interaction prediction.Bioinformatics (Oxford, England) · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Pretraining model for biological sequence data.Briefings in functional genomics · 2021
    Review
  14. Article
  15. Biological network analysis with deep learning.Briefings in bioinformatics · 2021
    Review
  16. Learning the Regulatory Code of Gene Expression.Frontiers in molecular biosciences · 2021
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Benoit PlayeCenter for Computational Biology, Mines ParisTech, PSL Research University, 60 Bd Saint-Michel, 75006, Paris, France.ORCID http://orcid.org/0000-0003-3836-2683
Veronique StovenCenter for Computational Biology, Mines ParisTech, PSL Research University, 60 Bd Saint-Michel, 75006, Paris, France. veronique.stoven@mines-paristech.fr.ORCID http://orcid.org/0000-0003-0828-0759

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemogenomics, also called proteochemometrics, covers a range of computational methods that can be used to predict protein-ligand interactions at large scales in the protein and chemical spaces. They differ from more classical ligand-based methods (also called QSAR) that predict ligands for a given protein receptor. In the context of drug discovery process, chemogenomics allows to tackle the question of predicting off-target proteins for drug candidates, one of the main causes of undesirable side-effects and failure within drugs development processes. The present study compares shallow and deep machine-learning approaches for chemogenomics, and explores data augmentation techniques for deep learning algorithms in chemogenomics. Shallow machine-learning algorithms rely on expert-based chemical and protein descriptors, while recent developments in deep learning algorithms enable to learn abstract numerical representations of molecular graphs and protein sequences, in order to optimise the performance of the prediction task. We first propose a formulation of chemogenomics with deep learning, called the chemogenomic neural network (CN), as a feed-forward neural network taking as input the combination of molecule and protein representations learnt by molecular graph and protein sequence encoders. We show that, on large datasets, the deep learning CN model outperforms state-of-the-art shallow methods, and competes with deep methods with expert-based descriptors. However, on small datasets, shallow methods present better prediction performance than deep learning methods. Then, we evaluate data augmentation techniques, namely multi-view and transfer learning, to improve the prediction performance of the chemogenomic neural network. We conclude that a promising research direction is to integrate heterogeneous sources of data such as auxiliary tasks for which large datasets are available, or independently, multiple molecule and protein attribute views.

Indexed as

ChemogenomicsDeep learningDrug virtual screeningGraph neural networks

Identifiers

PMID33431042
PMCPMC7011501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.